Alanosine

Alanosine

Systematic (IUPAC) name
(S)-2-Amino-3-[hydroxy(nitroso)amino]propanoic acid
Clinical data
Identifiers
CAS Registry Number	5854-93-3 Y
ATC code	None
PubChem	CID 22128
ChemSpider	20787 Y
UNII	2CNI71214Y Y
ChEMBL	CHEMBL452715 Y
Chemical data
Formula	C3H7N3O4
Molecular mass	149.1 g/mol
SMILES O=C(O)[C@@H](N)CN(O)N=O
InChI InChI=1S/C3H7N3O4/c4-2(3(7)8)1-6(10)5-9/h2,10H,1,4H2,(H,7,8)/t2-/m0/s1  Y Key:MLFKVJCWGUZWNV-REOHCLBHSA-N  Y
Y (what is this?)  (verify)

Alanosine (also called SDX-102) is a substance that is being studied for the treatment of pancreatic cancer.^[1] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.

References

1. ↑ Yu J (2001). "Alanosine (UCSD).". Curr Opin Investig Drugs 2 (11): 1623–30. PMID 11763167.